Paul Govern Archive — Page 17 of 53

April 7, 2022

Computer eyeballs graft-vs-host disease

A machine learning algorithm identified areas of skin affected by chronic graft-versus-host disease on par with clinicians, opening the door to streamlining and standardizing this measure of patient response to therapy.

Leon Cai explains his poster to Sharon Kam (center) and Katherine Lee at the 2022 Alzheimer’s Disease Research Day.
April 7, 2022

Event highlights research on Alzheimer’s disease

The third annual Vanderbilt Alzheimer’s Disease Research Day featured numerous presentations and concluded with a keynote address by Suzanne Craft, PhD, director of the Alzheimer’s Disease Research Center at Wake Forest University.

March 29, 2022

There’s no slowing arterial stiffening

Over 10 years, multiple healthy behaviors did not slow the progression of arterial stiffness, a risk factor for coronary artery disease, hypertension, stroke, atrial fibrillation and heart failure.

Inga Saknite, PhD, Eric Tkaczyk, MD, PhD, and colleagues are studying how white blood cell motion in the skin’s microvasculature can help predict which stem cell and bone marrow transplant patients would have a relapse of their blood cancer. (photo by Anne Rayner)
March 28, 2022

Study finds 10-second videos predict blood cancer relapse

Vanderbilt research shows that 10-second videos of white blood cell motion in the skin’s microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would have a relapse of their blood cancer.

An initiative at VUMC is helping to reduce automated alerts that are often triggered in the electronic health record.
March 24, 2022

VUMC Clickbusters program helps reduce EHR alerts

Vanderbilt’s Clickbusters program is helping to stem alert fatigue associated with the Medical Center’s clinical IT system.

March 17, 2022

U.S. precision medicine research program releases genomic data

The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants.